According to our latest research, the global cancer supportive care drugs market size reached USD 22.6 billion in 2024, reflecting the growing demand for adjunctive therapies in oncology. The market is expected to expand at a robust CAGR of 4.9% during the forecast period, with the total value projected to reach USD 34.8 billion by 2033. This upward trajectory is primarily driven by the increasing prevalence of cancer worldwide, advancements in cancer therapies, and a heightened focus on improving the quality of life for patients undergoing cancer treatments. https://growthmarketreports.com/report/cancer-supportive-care-drugs-market-global-industry-analysis